This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Would your CST programs, require FDA approval, to be available in USA?
On the sales contracts - do you expect to close deals at a price representing a pilot sale or a full sale? Meaning do you expect to give a big discount on the upcoming sales or are you fully priced in now?
When you tell you are expecting partnership agreements - does that mean you are currently in negotiation with some potential partners?
Will those that have subscribed for version 1 of your CST program, be automatically upgraded for the version 2, or do they have to buy licences, to get upgraded from version 1 to version 2?
Can you give an update on the German Mateser Hilfsdienst pilot program? Has the program started and what is the potential feedback and when is the pilot set to finish? Is there a probability that this can turn into a paid deal after the pilot program or is that not part of the discussion so far?
What is the estimated chance of getting the EIC Accelerator application approved? In the case of approval how will the grant be paid out, is it paid out upfront or do you need to have the capital to make the investments and afterward get it covered by the grant, this can be a big difference in the cash flow need?
What is your cash situation?
As I understand it the CST program has 14 sessions. Does that mean the treatment only lasts these 14 sessions or what happens afterwards, will the patient be able to start over again or do they need to find another program or treatment method afterwards? Do you expect to be able to treat Dementia patients for a longer period of time in the future?